Design, Synthesis, and Preliminary Biological Evaluation of GlcNAc‐6P Analogues for the Modulation of Phosphoacetylglucosamine Mutase 1 (AGM1/PGM3)

A library of GlcNAc 6‐ or 1‐phosphate analogues was designed, and each compound was evaluated computationally through docking studies for its binding affinity to AGM1/PGM3. The compounds with the highest binding affinity, as ranked through a docking score, were synthesised and screened for their ability to inhibit the production of UDP‐GlcNAc. A glycofused oxazoline analogue showed good inhibition, and gave significant results in vitro. A potential lead compound, able to inhibit the biosynthesis of UDP‐GlcNAc, was identified through computational screening. The compound was synthesised, and its activity was evaluated through an in‐vitro assay.